Wikidata

(Q61966495)

English

A Phase I Study of Lapatinib (Tykerb) Plus Ixabepilone (Ixempra) as 2nd-line Treatment for Patients With HER-2 Overexpressed Recurrent or Persistent Endometrial Carcinoma or Carcinosarcoma

clinical trial

In more languages
default for all languages
No label defined

No description defined

Statements

title
A Phase I Study of Lapatinib (Tykerb) Plus Ixabepilone (Ixempra) as 2nd-line Treatment for Patients With HER-2 Overexpressed Recurrent or Persistent Endometrial Carcinoma or Carcinosarcoma (English)
0 references
medical condition
carcinoma
0 references
carcinosarcoma
0 references
start time
March 2011
0 references
end time
April 2013
0 references
number of participants
24
0 references
minimum age
20 year
0 references
maximum age
75 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q61966495&oldid=2149432319"